Cleared Traditional

K955257 - SS102 DUAL CHANNEL SEP STIMULATOR

K955257 is an FDA 510(k) clearance for SS102 DUAL CHANNEL SEP STIMULATOR, manufactured by Axon Systems, Inc.. The device is a Class 2 Neurology device with product code GWF cleared through the Traditional 510(k) pathway after a 87-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1996
Decision
87d
Days
Class 2
Risk

K955257 is an FDA 510(k) clearance for the SS102 DUAL CHANNEL SEP STIMULATOR. Classified as Stimulator, Electrical, Evoked Response (product code GWF), Class II - Special Controls.

Submitted by Axon Systems, Inc. (Hauppauge, US). The FDA issued a Cleared decision on February 2, 1996 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1870 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Axon Systems, Inc. devices

FDA 510(k) Submission Details - K955257

510(k) Number K955257 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 07, 1995
Decision Date February 02, 1996
Days to Decision 87 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
61d faster than avg
Panel avg: 148d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWF Device Classification - Class 2, Special Controls

Product Code GWF Stimulator, Electrical, Evoked Response
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1870
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWF Stimulator, Electrical, Evoked Response

All 55
Devices cleared under the same product code (GWF) and FDA review panel - the closest regulatory comparables to K955257.
FOUR-CHANNEL PREAMPLIFIER
K962455 · Cadwell Laboratories, Inc. · Jan 1997
TWO-CHANNEL PREAMPLIFIER
K962457 · Cadwell Laboratories, Inc. · Jan 1997
CADWELL FOUR-/EIGHT-CHANNEL PREAMPLIFIER
K962458 · Cadwell Laboratories, Inc. · Jan 1997
NIHON KOHDEN NEUROPACK SIGMA MEB-5500A EVOKED RESPONSE & EMG MEASURING SYSTEM
K950208 · Nihon Kohden America, Inc. · May 1995
CADWELL 6200 A
K931428 · Cadwell Laboratories, Inc. · Jun 1993
CADWELL SIERRA
K924723 · Cadwell Laboratories, Inc. · Mar 1993